Citigroup’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Buy
181,696
+32,120
+21% +$260K ﹤0.01% 2275
2025
Q1
$1.25M Sell
149,576
-23,539
-14% -$197K ﹤0.01% 2411
2024
Q4
$1.37M Buy
173,115
+20,664
+14% +$164K ﹤0.01% 2380
2024
Q3
$1.27M Buy
152,451
+80,068
+111% +$666K ﹤0.01% 2385
2024
Q2
$460K Buy
72,383
+6,254
+9% +$39.7K ﹤0.01% 2752
2024
Q1
$401K Buy
66,129
+19,137
+41% +$116K ﹤0.01% 2968
2023
Q4
$285K Buy
46,992
+46,931
+76,936% +$285K ﹤0.01% 3016
2023
Q3
$257 Sell
61
-36,242
-100% -$153K ﹤0.01% 4526
2023
Q2
$113K Buy
36,303
+32,054
+754% +$99.4K ﹤0.01% 3520
2023
Q1
$5.91K Sell
4,249
-671
-14% -$933 ﹤0.01% 4216
2022
Q4
$9.79K Sell
4,920
-931
-16% -$1.85K ﹤0.01% 4140
2022
Q3
$11K Sell
5,851
-80,918
-93% -$152K ﹤0.01% 4210
2022
Q2
$276K Buy
86,769
+73,169
+538% +$233K ﹤0.01% 3007
2022
Q1
$57K Sell
13,600
-17,582
-56% -$73.7K ﹤0.01% 3968
2021
Q4
$149K Sell
31,182
-11,560
-27% -$55.2K ﹤0.01% 3766
2021
Q3
$228K Buy
42,742
+25,740
+151% +$137K ﹤0.01% 3325
2021
Q2
$87K Buy
17,002
+4,076
+32% +$20.9K ﹤0.01% 3901
2021
Q1
$87K Sell
12,926
-15,393
-54% -$104K ﹤0.01% 3772
2020
Q4
$130K Sell
28,319
-6,199
-18% -$28.5K ﹤0.01% 3505
2020
Q3
$134K Buy
34,518
+5,550
+19% +$21.5K ﹤0.01% 2981
2020
Q2
$138K Sell
28,968
-6,418
-18% -$30.6K ﹤0.01% 3269
2020
Q1
$123K Buy
35,386
+421
+1% +$1.46K ﹤0.01% 3162
2019
Q4
$169K Buy
34,965
+21,253
+155% +$103K ﹤0.01% 3240
2019
Q3
$40K Sell
13,712
-118,059
-90% -$344K ﹤0.01% 3875
2019
Q2
$945K Buy
131,771
+119,578
+981% +$858K ﹤0.01% 2182
2019
Q1
$173K Buy
12,193
+13
+0.1% +$184 ﹤0.01% 3217
2018
Q4
$165K Sell
12,180
-22,394
-65% -$303K ﹤0.01% 3215
2018
Q3
$767K Sell
34,574
-38,108
-52% -$845K ﹤0.01% 2196
2018
Q2
$1.19M Buy
+72,682
New +$1.19M ﹤0.01% 1759